SYN Annual Total Long Term Liabilities
$1.40 M
+$1.22 M+654.30%
31 December 2021
Summary:
As of February 5, 2025, SYN annual total long term liabilities is $1.40 million, with the most recent change of +$1.22 million (+654.30%) on December 31, 2021. During the last 3 years, it has risen by +$1.10 million (+364.57%).SYN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Quarterly Long Term Liabilities
$7.39 M
-$2.60 M-26.04%
30 June 2022
Summary:
As of February 5, 2025, SYN quarterly total long term liabilities is $7.39 million, with the most recent change of -$2.60 million (-26.04%) on June 30, 2022. Over the past year, it has increased by +$5.97 million (+418.44%).SYN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +654.3% | +418.4% |
| 3 y3 years | +364.6% | +1130.1% |
| 5 y5 years | +249.0% | +1550.2% |
SYN Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -86.6% | -40.5% |
Synthetic Biologics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $7.39 M(-26.0%) |
| Mar 2022 | - | $10.00 M(+612.5%) |
| Dec 2021 | $1.40 M(+654.3%) | $1.40 M(+0.1%) |
| Sept 2021 | - | $1.40 M(-1.8%) |
| June 2021 | - | $1.43 M(+1220.4%) |
| Mar 2021 | - | $108.00 K(-41.9%) |
| Dec 2020 | $186.00 K(-60.7%) | $186.00 K(-28.7%) |
| Sept 2020 | - | $261.00 K(-21.9%) |
| June 2020 | - | $334.00 K(-17.5%) |
| Mar 2020 | - | $405.00 K(-14.4%) |
| Dec 2019 | $473.00 K(+56.6%) | $473.00 K(-12.2%) |
| Sept 2019 | - | $539.00 K(-10.3%) |
| June 2019 | - | $601.00 K(-9.2%) |
| Mar 2019 | - | $662.00 K(+119.2%) |
| Dec 2018 | $302.00 K(-24.9%) | $302.00 K(-8.2%) |
| Sept 2018 | - | $329.00 K(-6.8%) |
| June 2018 | - | $353.00 K(-6.4%) |
| Mar 2018 | - | $377.00 K(-6.2%) |
| Dec 2017 | $402.00 K(-18.3%) | $402.00 K(-96.8%) |
| Sept 2017 | - | $12.42 M(+2671.9%) |
| June 2017 | - | $448.00 K(-4.7%) |
| Mar 2017 | - | $470.00 K(-4.5%) |
| Dec 2016 | $492.00 K(+84.3%) | $492.00 K(+129.9%) |
| Sept 2016 | - | $214.00 K(-5.7%) |
| June 2016 | - | $227.00 K(-5.4%) |
| Mar 2016 | - | $240.00 K(-10.1%) |
| Dec 2015 | $267.00 K(>+9900.0%) | $267.00 K(+34.8%) |
| Sept 2015 | - | $198.00 K(>+9900.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00 | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2011 | - | $2300.00(0.0%) |
| June 2011 | - | $2300.00(-86.7%) |
| Mar 2011 | - | $17.30 K(-45.9%) |
| Dec 2010 | $32.00 K(-69.8%) | $32.00 K(-70.7%) |
| Sept 2010 | - | $109.20 K(-13.7%) |
| June 2010 | - | $126.60 K(-10.5%) |
| Mar 2010 | - | $141.50 K(+33.7%) |
| Dec 2009 | $105.80 K(>+9900.0%) | $105.80 K(-39.6%) |
| Sept 2009 | - | $175.20 K(+43.3%) |
| June 2009 | - | $122.30 K(-10.9%) |
| Mar 2009 | - | $137.30 K(>+9900.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2007 | - | $600.00 K(+71.4%) |
| June 2007 | - | $350.00 K(-12.5%) |
| Mar 2007 | - | $400.00 K(-96.2%) |
| Dec 2005 | $0.00(-100.0%) | - |
| Mar 2003 | - | $10.50 M(0.0%) |
| Dec 2002 | $10.50 M(+110.0%) | $10.50 M(-8.7%) |
| Sept 2002 | - | $11.50 M(0.0%) |
| June 2002 | - | $11.50 M(+15.0%) |
| Mar 2002 | - | $10.00 M(+100.0%) |
| Dec 2001 | $5.00 M(+150.0%) | $5.00 M(+66.7%) |
| Sept 2001 | - | $3.00 M(+50.0%) |
| June 2001 | - | $2.00 M(0.0%) |
| Mar 2001 | - | $2.00 M(0.0%) |
| Dec 2000 | $2.00 M(0.0%) | $2.00 M(0.0%) |
| Sept 2000 | - | $2.00 M(0.0%) |
| June 2000 | - | $2.00 M(0.0%) |
| Mar 2000 | - | $2.00 M(0.0%) |
| Dec 1999 | $2.00 M(+100.0%) | $2.00 M(+33.3%) |
| June 1999 | - | $1.50 M(0.0%) |
| Mar 1999 | - | $1.50 M(+50.0%) |
| Dec 1998 | $1.00 M(-37.5%) | $1.00 M(+100.0%) |
| Sept 1998 | - | $500.00 K(-44.4%) |
| Mar 1998 | - | $900.00 K(-43.8%) |
| Dec 1997 | $1.60 M | $1.60 M(-11.1%) |
| Sept 1997 | - | $1.80 M |
FAQ
- What is Synthetic Biologics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Synthetic Biologics?
- What is Synthetic Biologics annual total long term liabilities year-on-year change?
- What is Synthetic Biologics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Synthetic Biologics?
- What is Synthetic Biologics quarterly long term liabilities year-on-year change?
What is Synthetic Biologics annual total long term liabilities?
The current annual total long term liabilities of SYN is $1.40 M
What is the all time high annual total long term liabilities for Synthetic Biologics?
Synthetic Biologics all-time high annual total long term liabilities is $10.50 M
What is Synthetic Biologics annual total long term liabilities year-on-year change?
Over the past year, SYN annual total long term liabilities has changed by +$1.22 M (+654.30%)
What is Synthetic Biologics quarterly total long term liabilities?
The current quarterly long term liabilities of SYN is $7.39 M
What is the all time high quarterly long term liabilities for Synthetic Biologics?
Synthetic Biologics all-time high quarterly total long term liabilities is $12.42 M
What is Synthetic Biologics quarterly long term liabilities year-on-year change?
Over the past year, SYN quarterly total long term liabilities has changed by +$5.97 M (+418.44%)